PubMed · 15464374
Islet- and stem-cell-based tissue engineering in diabetes.
Abstract
New sources of insulin-producing cells are needed to overcome the limited availability of islet tissue for transplantation to diabetic patients. The engineering of murine or human transformed beta-cell lines and of non beta-cells has progressed slowly in recent years, while significant achievements have been claimed in the differentiation of insulin-producing cells from embryonic and adult stem cells. Some of the results have been questioned, however, and the generated cells lack many characteristics of differentiated beta-cells. A much better understanding of the processes that govern the expansion and differentiation of stem cells is needed.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Eduard Montanya. 2004. Islet- and stem-cell-based tissue engineering in diabetes.. https://doi.org/10.1016/j.copbio.2004.08.011
Cite the original work for its findings. Save a collection to share your selection of sources.